dermatology

Popit and Almirall’s new app tracks adherence to psoriasis med

https://pharmaphorum.com/news/popit-and-almiralls-new-app-tracks-adherence-to-psoriasis-med/

FDA sets April verdict for Pfizer’s “underestimated” atopic dermatitis drug

https://pharmaphorum.com/news/fda-sets-april-verdict-for-pfizers-underestimated-atopic-dermatitis-drug/

FDA hands Cassiopea its first approval, for acne drug Winlevi

https://pharmaphorum.com/news/fda-hands-cassiopea-its-first-approval-for-acne-drug-winlevi/

UCB’s IL-17 latecomer bimekizumab beats Cosentyx in psoriasis trial

https://pharmaphorum.com/news/ucbs-il-17-latecomer-bimekizumab-beats-cosentyx-in-psoriasis-trial/

Novartis takes $485m hit after axing eczema drug from pipeline

https://pharmaphorum.com/news/novartis-takes-485m-hit-after-axing-eczema-drug-from-pipeline/

LEO eyeing 2021 US launch for eczema drug tralokinumab

https://pharmaphorum.com/news/leo-eyeing-2021-us-launch-for-eczema-drug-tralokinumab/

Dermatology Devices Market Size Will Achieve 11.9% CAGR From 2019 To 2025

https://pharmaphorum.com/partner-content/dermatology-devices-market-size-will-achieve-11-9-cagr-from-2019-to-2025/

Eyeing Dupixent’s territory, Leo Pharma files tralokinumab in EU

https://pharmaphorum.com/news/eyeing-dupixents-territory-leo-pharma-files-tralokinumab-in-eu/

https://pharmaphorum.com/events/hit-the-jak-pot-in-global-race-to-treat-covid-19/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search